National Institute of Mental Health; Notice of Workshop, 38715-38716 [2018-16793]

Download as PDF Federal Register / Vol. 83, No. 152 / Tuesday, August 7, 2018 / Notices daltland on DSKBBV9HB2PROD with NOTICES amended, notice is hereby given of a meeting of the National Advisory General Medical Sciences Council. The meeting will be open to the public as indicated below, with a short public comment period at the end. Attendance is limited by the space available. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the Contact Person listed below in advance of the meeting. The open session will also be videocast and can be accessed from the NIH Videocasting and Podcasting website (https:// videocast.nih.gov). The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Advisory General Medical Sciences Council. Date: September 13–14, 2018. Time: September 13, 2018, 9:00 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health Natcher Building, Conference Rooms E1 & E2, 45 Center Drive, Bethesda, MD 20892. Time: September 14, 2018, 8:30 a.m. to 12:00 p.m. Agenda: For the discussion of program policies and issues; opening remarks; report of the Director, NIGMS; and other business of the Council. Place: National Institutes of Health Natcher Building, Conference Rooms E1 & E2, 45 Center Drive, Bethesda, MD 20892. Contact Person: Ann A. Hagan, Ph.D., Associate Director for Extramural Activities, NIGMS, NIH, DHHS, 45 Center Drive, Room 2AN24B, MSC 6200, Bethesda, MD 20892– 6200, (301) 594–4499, hagana@ nigms.nih.gov. Any interested person may file written comments with the committee by forwarding the statement to the Contact Person listed on this notice. The statement should include the name, address, telephone number and when applicable, the business or professional affiliation of the interested person. In the interest of security, NIH has instituted stringent procedures for entrance onto the NIH campus. All visitor vehicles, including taxicabs, hotel, and airport shuttles will be inspected before being allowed on campus. Visitors will be asked to show one form of identification (for example, a government-issued photo ID, driver’s license, or passport) and to state the purpose of their visit. VerDate Sep<11>2014 16:54 Aug 06, 2018 Jkt 244001 Information is also available on the Institute’s/Center’s home page: https:// www.nigms.nih.gov/About/Council, where an agenda and any additional information for the meeting will be posted when available. (Catalogue of Federal Domestic Assistance Program Nos. 93.859, Pharmacology, Physiology, and Biological Chemistry Research; 93.859, Biomedical Research and Research Training, National Institutes of Health, HHS) Dated: August 1, 2018. Melanie J. Pantoja, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2018–16791 Filed 8–6–18; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Mental Health; Notice of Workshop Notice is hereby given of a workshop convened by the Interagency Autism Coordinating Committee (IACC). The purpose of the 2018 IACC Workshop, Addressing the Health Needs of People with Autism Spectrum Disorder (ASD), is to convene a working group of the IACC that will focus on health needs and outcomes among individuals with ASD. The working group will use this workshop to discuss health epidemiology, patient-provider interactions, and co-occurring health conditions that affect individuals with ASD. The workshop will be open to the public, will include time for public comments, and will be accessible by live webcast and conference call. Name of Committee: Interagency Autism Coordinating Committee (IACC). Type of meeting: 2018 IACC Workshop on Addressing the Health Needs of People with Autism Spectrum Disorder (ASD). Date: Thursday, September 27, 2018. Time: 8:30 a.m. to 5:00 p.m. Eastern Time (ET). Agenda: The workshop will focus discussion on the health and wellness of individuals with ASD, including health epidemiology, patient-provider interaction, and the state of the science on commonly cooccurring health conditions affecting individuals on the autism spectrum. Place: National Institute of Mental Health (NIMH), 6001 Executive Boulevard, Neuroscience Center (NSC), Conference Rooms C, D, and E, Rockville, MD 20852. Conference Call: 800–369–1744. Access Code: 6697418. Webcast Live: https://videocast.nih.gov/. Cost: The meeting is free and open to the public. Registration: Pre-registration is recommended to expedite check-in. Seating in the meeting room is limited to room PO 00000 Frm 00039 Fmt 4703 Sfmt 4703 38715 capacity and on a first come, first serve basis. To register, please visit www.iacc.hhs.gov. Deadlines: Notification of intent to present oral comments: Friday, September 14, 2018 by 5:00 p.m. ET. Submission of written/electronic statement for oral comments: Wednesday, September 19, 2018 by 5:00 p.m. ET. Final deadline for submission of written comments: Wednesday, September 19, 2018 by 5:00 p.m. ET. For IACC public comment guidelines, please see: https://iacc.hhs.gov/ meetings/public-comments/guidelines/. Access: White Flint Metro Station (Red Line). Contact Person: Ms. Angelice Mitrakas, Office of Autism Research Coordination, National Institute of Mental Health, National Institutes of Health, 6001 Executive Boulevard, Room 6182A, Bethesda, MD 20892–9669, Phone: 301–435–9269, Email: IACCPublicInquiries@mail.nih.gov. The IACC invites oral and written public-related comments relevant to the topic of the workshop. Individuals interested in presenting oral comments must notify the Contact Person listed on this notice by 5:00 p.m. ET on Friday, September 14, 2018 with their request to present oral comments at the meeting, and a written/electronic copy of the oral presentation/statement must be submitted by 5:00 p.m. ET on Wednesday, September 19, 2018. A limited number of slots for oral comment are available and will be assigned on a first come, first serve basis. Only one representative of an organization will be allowed to present oral comments at this meeting; other representatives of the same group may provide written comments. If the oral comment session is full, individuals who could not be accommodated are welcome to provide written comments instead. Comments to be read or presented in the meeting will be assigned a 3-minute time slot, but a longer version may be submitted in writing for the record. Commenters going beyond their allotted time in the meeting may be asked to conclude immediately to allow other comments and presentations to proceed on schedule. Any interested person may submit written public comments to the IACC prior to the meeting by emailing the comments to IACCPublicInquiries@ mail.nih.gov, or by submitting comments at the web link: https:// iacc.hhs.gov/meetings/publiccomments/submit/index.jsp by 5:00 p.m. ET on Wednesday, September 19, 2018. The comments should include the name, address, telephone number and when applicable, the business or professional affiliation of the interested person. NIMH anticipates written public comments received by 5:00 p.m. ET on E:\FR\FM\07AUN1.SGM 07AUN1 daltland on DSKBBV9HB2PROD with NOTICES 38716 Federal Register / Vol. 83, No. 152 / Tuesday, August 7, 2018 / Notices Wednesday, September 19, 2018 will be presented to the working group prior to the workshop. Any written comments received after the 5:00 p.m. ET, Wednesday, September 19, 2018 deadline through Tuesday, September 25, 2018 will be provided to the working group either before or after the meeting, depending on the volume of comments received and the time required to process them in accordance with privacy regulations and other applicable Federal policies. All written public comments and oral public comment statements received by the deadlines for both oral and written public comments will be provided to the IACC for their consideration and will become part of the public record. Attachments of copyrighted publications are not permitted, but web links or citations for any copyrighted works cited may be provided. In the 2009 IACC Strategic Plan, the IACC listed the ‘‘Spirit of Collaboration’’ as one of its core values, stating that, ‘‘We will treat others with respect, listen to diverse views with open minds, discuss submitted public comments, and foster discussions where participants can comfortably offer opposing opinions.’’ In keeping with this core value, the IACC and the NIMH Office of Autism Research Coordination (OARC) ask that members of the public who provide public comments or participate in meetings of the IACC also seek to treat others with respect and consideration in their communications and actions, even when discussing issues of genuine concern or disagreement. Remote Access: The meeting will be open to the public through a conference call phone number and webcast live on the internet. Members of the public who participate using the conference call phone number will be able to listen to the meeting but will not be heard. If you experience any technical problems with the webcast or conference call, please send an e- mail to IACCPublicInquiries@ mail.nih.gov. Individuals wishing to participate in person or by using these electronic services and who need special assistance, such as captioning of the conference call or other reasonable accommodations, should submit a request to the Contact Person listed on this notice at least 5 days prior to the meeting. Special Accommodations: Individuals who participate in person or by using these electronic services and who need special assistance, such as captioning of the conference call or other reasonable accommodations, should submit a request to the Contact Person listed on VerDate Sep<11>2014 16:54 Aug 06, 2018 Jkt 244001 this notice at least 5 days prior to the meeting. Security: Visitors will be asked to show one form of identification (for example, a government-issued photo ID, driver’s license, or passport) and to state the purpose of their visit. Also, as a part of security procedures, attendees should be prepared to present a photo ID at the meeting registration desk during the check-in process. Pre-registration is recommended. Seating will be limited to the room capacity and seats will be on a first come, first serve basis, with expedited check-in for those who are pre-registered. Meeting schedule subject to change. Information about the IACC is available on the website: https://www.iacc.hhs.gov. Dated: August 1, 2018. Melanie J. Pantoja, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2018–16793 Filed 8–6–18; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute on Aging; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute on Aging Initial Review Group, Biological Aging Review Committee NIA–B. Date: September 27–28, 2018. Time: 2:00 p.m. to 3:00 p.m. Agenda: To review and evaluate grant applications. Place: Bethesda Marriott, 5151 Pooks Hill Rd., Bethesda, MD 20814 (Telephone Conference Call). Contact Person: Bita Nakhai, Ph.D., Scientific Review Branch, National Institute on Aging, Gateway Bldg., 2C212, 7201 Wisconsin Avenue, Bethesda, MD 20814, 301–402–7701, nakhaib@nia.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.866, Aging Research, National Institutes of Health, HHS) PO 00000 Frm 00040 Fmt 4703 Sfmt 4703 Dated: August 1, 2018. Melanie J. Pantoja, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2018–16788 Filed 8–6–18; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Government-Owned Inventions; Availability for Licensing AGENCY: National Institutes of Health, HHS. ACTION: Notice. The invention listed below is owned by an agency of the U.S. Government and is available for licensing to achieve expeditious commercialization of results of federally-funded research and development. Foreign patent applications are filed on selected inventions to extend market coverage for companies and may also be available for licensing. FOR FURTHER INFORMATION CONTACT: Vince Contreras, Ph.D., 240–669–2823; vince.contreras@nih.gov. Licensing information and copies of the U.S. patent application listed below may be obtained by communicating with the indicated licensing contact at the Technology Transfer and Intellectual Property Office, National Institute of Allergy and Infectious Diseases, 5601 Fishers Lane, Rockville, MD 20852; tel. 301–496–2644. A signed Confidential Disclosure Agreement will be required to receive copies of unpublished patent applications. SUPPLEMENTARY INFORMATION: Technology description follows. SUMMARY: Substitutions-Modified Prefusion RSV F Proteins and Their Use Description of Technology: The respiratory syncytial virus (RSV) fusion (F) glycoprotein is the primary target of neutralizing antibodies. The F glycoprotein exists in at least two conformations, a meta-stable prefusion state, and an extremely stable postfusion state. Both states share several epitopes targeted by neutralizing antibodies, but it has been demonstrated that the prefusion conformation of F contains at least one epitope not present in the postfusion conformation. Natural infection results in neutralizing antibodies that are primarily directed against the prefusion conformation of F, not its postfusion conformation. The instability of the prefusion form of F has E:\FR\FM\07AUN1.SGM 07AUN1

Agencies

[Federal Register Volume 83, Number 152 (Tuesday, August 7, 2018)]
[Notices]
[Pages 38715-38716]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-16793]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Mental Health; Notice of Workshop

    Notice is hereby given of a workshop convened by the Interagency 
Autism Coordinating Committee (IACC).
    The purpose of the 2018 IACC Workshop, Addressing the Health Needs 
of People with Autism Spectrum Disorder (ASD), is to convene a working 
group of the IACC that will focus on health needs and outcomes among 
individuals with ASD. The working group will use this workshop to 
discuss health epidemiology, patient-provider interactions, and co-
occurring health conditions that affect individuals with ASD. The 
workshop will be open to the public, will include time for public 
comments, and will be accessible by live webcast and conference call.

    Name of Committee: Interagency Autism Coordinating Committee 
(IACC).
    Type of meeting: 2018 IACC Workshop on Addressing the Health 
Needs of People with Autism Spectrum Disorder (ASD).
    Date: Thursday, September 27, 2018.
    Time: 8:30 a.m. to 5:00 p.m. Eastern Time (ET).
    Agenda: The workshop will focus discussion on the health and 
wellness of individuals with ASD, including health epidemiology, 
patient-provider interaction, and the state of the science on 
commonly co-occurring health conditions affecting individuals on the 
autism spectrum.
    Place: National Institute of Mental Health (NIMH), 6001 
Executive Boulevard, Neuroscience Center (NSC), Conference Rooms C, 
D, and E, Rockville, MD 20852.
    Conference Call: 800-369-1744.
    Access Code: 6697418.
    Webcast Live: https://videocast.nih.gov/.
    Cost: The meeting is free and open to the public.
    Registration: Pre-registration is recommended to expedite check-
in. Seating in the meeting room is limited to room capacity and on a 
first come, first serve basis. To register, please visit 
www.iacc.hhs.gov.
    Deadlines: Notification of intent to present oral comments: 
Friday, September 14, 2018 by 5:00 p.m. ET.
    Submission of written/electronic statement for oral comments: 
Wednesday, September 19, 2018 by 5:00 p.m. ET.
    Final deadline for submission of written comments: Wednesday, 
September 19, 2018 by 5:00 p.m. ET. For IACC public comment 
guidelines, please see: https://iacc.hhs.gov/meetings/public-comments/guidelines/.
    Access: White Flint Metro Station (Red Line).
    Contact Person: Ms. Angelice Mitrakas, Office of Autism Research 
Coordination, National Institute of Mental Health, National 
Institutes of Health, 6001 Executive Boulevard, Room 6182A, 
Bethesda, MD 20892-9669, Phone: 301-435-9269, Email: 
[email protected].

    The IACC invites oral and written public-related comments relevant 
to the topic of the workshop. Individuals interested in presenting oral 
comments must notify the Contact Person listed on this notice by 5:00 
p.m. ET on Friday, September 14, 2018 with their request to present 
oral comments at the meeting, and a written/electronic copy of the oral 
presentation/statement must be submitted by 5:00 p.m. ET on Wednesday, 
September 19, 2018. A limited number of slots for oral comment are 
available and will be assigned on a first come, first serve basis. Only 
one representative of an organization will be allowed to present oral 
comments at this meeting; other representatives of the same group may 
provide written comments. If the oral comment session is full, 
individuals who could not be accommodated are welcome to provide 
written comments instead. Comments to be read or presented in the 
meeting will be assigned a 3-minute time slot, but a longer version may 
be submitted in writing for the record. Commenters going beyond their 
allotted time in the meeting may be asked to conclude immediately to 
allow other comments and presentations to proceed on schedule.
    Any interested person may submit written public comments to the 
IACC prior to the meeting by emailing the comments to 
[email protected], or by submitting comments at the web 
link: https://iacc.hhs.gov/meetings/public-comments/submit/index.jsp by 
5:00 p.m. ET on Wednesday, September 19, 2018. The comments should 
include the name, address, telephone number and when applicable, the 
business or professional affiliation of the interested person. NIMH 
anticipates written public comments received by 5:00 p.m. ET on

[[Page 38716]]

Wednesday, September 19, 2018 will be presented to the working group 
prior to the workshop. Any written comments received after the 5:00 
p.m. ET, Wednesday, September 19, 2018 deadline through Tuesday, 
September 25, 2018 will be provided to the working group either before 
or after the meeting, depending on the volume of comments received and 
the time required to process them in accordance with privacy 
regulations and other applicable Federal policies. All written public 
comments and oral public comment statements received by the deadlines 
for both oral and written public comments will be provided to the IACC 
for their consideration and will become part of the public record. 
Attachments of copyrighted publications are not permitted, but web 
links or citations for any copyrighted works cited may be provided.
    In the 2009 IACC Strategic Plan, the IACC listed the ``Spirit of 
Collaboration'' as one of its core values, stating that, ``We will 
treat others with respect, listen to diverse views with open minds, 
discuss submitted public comments, and foster discussions where 
participants can comfortably offer opposing opinions.'' In keeping with 
this core value, the IACC and the NIMH Office of Autism Research 
Coordination (OARC) ask that members of the public who provide public 
comments or participate in meetings of the IACC also seek to treat 
others with respect and consideration in their communications and 
actions, even when discussing issues of genuine concern or 
disagreement.
    Remote Access: The meeting will be open to the public through a 
conference call phone number and webcast live on the internet. Members 
of the public who participate using the conference call phone number 
will be able to listen to the meeting but will not be heard. If you 
experience any technical problems with the webcast or conference call, 
please send an e- mail to [email protected]. Individuals 
wishing to participate in person or by using these electronic services 
and who need special assistance, such as captioning of the conference 
call or other reasonable accommodations, should submit a request to the 
Contact Person listed on this notice at least 5 days prior to the 
meeting.
    Special Accommodations: Individuals who participate in person or by 
using these electronic services and who need special assistance, such 
as captioning of the conference call or other reasonable 
accommodations, should submit a request to the Contact Person listed on 
this notice at least 5 days prior to the meeting.
    Security: Visitors will be asked to show one form of identification 
(for example, a government-issued photo ID, driver's license, or 
passport) and to state the purpose of their visit. Also, as a part of 
security procedures, attendees should be prepared to present a photo ID 
at the meeting registration desk during the check-in process. Pre-
registration is recommended. Seating will be limited to the room 
capacity and seats will be on a first come, first serve basis, with 
expedited check-in for those who are pre-registered.
    Meeting schedule subject to change. Information about the IACC is 
available on the website: https://www.iacc.hhs.gov.

    Dated: August 1, 2018.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2018-16793 Filed 8-6-18; 8:45 am]
 BILLING CODE 4140-01-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.